Literature DB >> 7556505

Individual differences in hypothalamic-pituitary-adrenal activity in later life and hippocampal aging.

M J Meaney1, D O'Donnell, W Rowe, B Tannenbaum, A Steverman, M Walker, N P Nair, S Lupien.   

Abstract

Variation in magnitude of cognitive decline in later life is a central feature of human aging. The more severe forms of dementias, such as Alzheimer's disease, clearly define one end of the spectrum. However, among those showing no obvious signs of clinical dementia there are considerable individual differences. Thus, although evidence for learning, memory, and language loss appears in some individuals as early as 50-55 years of age, many people continue to function alertly well into their 90s. These individuals exemplify what Rowe and Kahn (1987) have termed "successful" aging. The wide variability in CNS aging, often a nuisance factor in studies, are becoming a major focus for brain aging research (e.g., Gage et al., 1984;Gallager and Pelleymounter, 1988; Aitken and Meaney, 1990; Issa et al., 1990). Our studies over the past few years have added support to the idea that individual differences in hypothalamic-pituitary-adrenal (HPA) activity can account for part of the variation seen in neurological function among the elderly. In this article we discuss the evidence for the idea that adrenal glucocorticoids can compromise hippocampal function and, thus, produce cognitive impairments, as well as the potential mechanisms for these effects.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7556505     DOI: 10.1016/0531-5565(94)00065-b

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  26 in total

1.  Modulation of 11beta-hydroxysteroid dehydrogenase type 1 activity by 1,5-substituted 1H-tetrazoles.

Authors:  Scott P Webster; Margaret Binnie; Kirsty M M McConnell; Karen Sooy; Peter Ward; Michael F Greaney; Andy Vinter; T David Pallin; Hazel J Dyke; Matthew I A Gill; Ines Warner; Jonathan R Seckl; Brian R Walker
Journal:  Bioorg Med Chem Lett       Date:  2010-04-18       Impact factor: 2.823

Review 2.  Stress and plasticity in the limbic system.

Authors:  Robert M Sapolsky
Journal:  Neurochem Res       Date:  2003-11       Impact factor: 3.996

Review 3.  Nuclear receptor coregulators are new players in nervous system development and function.

Authors:  Eijun Nishihara; Bert W O'Malley; Jianming Xu
Journal:  Mol Neurobiol       Date:  2004-12       Impact factor: 5.590

4.  Susceptibility to induction of long-term depression is associated with impaired memory in aged Fischer 344 rats.

Authors:  Thomas C Foster; Ashok Kumar
Journal:  Neurobiol Learn Mem       Date:  2007-02-05       Impact factor: 2.877

Review 5.  11beta-HSD1, inflammation, metabolic disease and age-related cognitive (dys)function.

Authors:  Karen E Chapman; Jonathan R Seckl
Journal:  Neurochem Res       Date:  2007-10-25       Impact factor: 3.996

6.  11beta-hydroxysteroid dehydrogenase type 1 expression is increased in the aged mouse hippocampus and parietal cortex and causes memory impairments.

Authors:  Megan C Holmes; Roderick N Carter; June Noble; Shruti Chitnis; Amy Dutia; Janice M Paterson; John J Mullins; Jonathan R Seckl; Joyce L W Yau
Journal:  J Neurosci       Date:  2010-05-19       Impact factor: 6.167

7.  Neuroanatomic Differences Associated With Stress Susceptibility and Resilience.

Authors:  Christoph Anacker; Jan Scholz; Kieran J O'Donnell; Rylan Allemang-Grand; Josie Diorio; Rosemary C Bagot; Eric J Nestler; René Hen; Jason P Lerch; Michael J Meaney
Journal:  Biol Psychiatry       Date:  2015-08-18       Impact factor: 13.382

8.  11beta-hydroxysteroid dehydrogenase type 1 deficiency prevents memory deficits with aging by switching from glucocorticoid receptor to mineralocorticoid receptor-mediated cognitive control.

Authors:  Joyce L W Yau; June Noble; Jonathan R Seckl
Journal:  J Neurosci       Date:  2011-03-16       Impact factor: 6.167

Review 9.  A new glucocorticoid hypothesis of brain aging: implications for Alzheimer's disease.

Authors:  Philip W Landfield; Eric M Blalock; Kuey-Chu Chen; Nada M Porter
Journal:  Curr Alzheimer Res       Date:  2007-04       Impact factor: 3.498

10.  11Beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics.

Authors:  Thekkepat C Sandeep; Joyce L W Yau; Alasdair M J MacLullich; June Noble; Ian J Deary; Brian R Walker; Jonathan R Seckl
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.